Emmrich S - Search Results

1

E2F1 in melanoma progression and metastasis.

Alla V, Engelmann D, Niemetz A, Pahnke J, Schmidt A, Kunz M, Emmrich S, Steder M, Koczan D, Pützer BM. Alla V, et al. Among authors: emmrich s. J Natl Cancer Inst. 2010 Jan 20;102(2):127-33. doi: 10.1093/jnci/djp458. Epub 2009 Dec 21. J Natl Cancer Inst. 2010. PMID: 20026813

2

Checks and balances: E2F-microRNA crosstalk in cancer control.

Emmrich S, Pützer BM. Emmrich S, et al. Cell Cycle. 2010 Jul 1;9(13):2555-67. doi: 10.4161/cc.9.13.12061. Cell Cycle. 2010. PMID: 20581444 Review.

3

E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.

Alla V, Kowtharapu BS, Engelmann D, Emmrich S, Schmitz U, Steder M, Pützer BM. Alla V, et al. Among authors: emmrich s. Cell Cycle. 2012 Aug 15;11(16):3067-78. doi: 10.4161/cc.21476. Epub 2012 Aug 8. Cell Cycle. 2012. PMID: 22871739 Free PMC article.

4

The E2F1-miRNA cancer progression network.

Knoll S, Emmrich S, Pützer BM. Knoll S, et al. Among authors: emmrich s. Adv Exp Med Biol. 2013;774:135-47. doi: 10.1007/978-94-007-5590-1_8. Adv Exp Med Biol. 2013. PMID: 23377972 Review.

5

Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.

Emmrich S, Wang W, John K, Li W, Pützer BM. Emmrich S, et al. Mol Cancer. 2009 Aug 11;8:61. doi: 10.1186/1476-4598-8-61. Mol Cancer. 2009. PMID: 19671150 Free PMC article.

6

LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia.

Emmrich S, Streltsov A, Schmidt F, Thangapandi VR, Reinhardt D, Klusmann JH. Emmrich S, et al. Mol Cancer. 2014 Jul 15;13:171. doi: 10.1186/1476-4598-13-171. Mol Cancer. 2014. PMID: 25027842 Free PMC article.

7

miR-99a/100~125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling.

Emmrich S, Rasche M, Schöning J, Reimer C, Keihani S, Maroz A, Xie Y, Li Z, Schambach A, Reinhardt D, Klusmann JH. Emmrich S, et al. Genes Dev. 2014 Apr 15;28(8):858-74. doi: 10.1101/gad.233791.113. Genes Dev. 2014. PMID: 24736844 Free PMC article.

8

lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling.

Lu Y, Zhao X, Liu Q, Li C, Graves-Deal R, Cao Z, Singh B, Franklin JL, Wang J, Hu H, Wei T, Yang M, Yeatman TJ, Lee E, Saito-Diaz K, Hinger S, Patton JG, Chung CH, Emmrich S, Klusmann JH, Fan D, Coffey RJ. Lu Y, et al. Among authors: emmrich s. Nat Med. 2017 Nov;23(11):1331-1341. doi: 10.1038/nm.4424. Epub 2017 Oct 16. Nat Med. 2017. PMID: 29035371 Free PMC article.

9

The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis.

Alejo-Valle O, Weigert K, Bhayadia R, Ng M, Issa H, Beyer C, Emmrich S, Schuschel K, Ihling C, Sinz A, Zimmermann M, Wickenhauser C, Flasinski M, Regenyi E, Labuhn M, Reinhardt D, Yaspo ML, Heckl D, Klusmann JH. Alejo-Valle O, et al. Among authors: emmrich s. Blood. 2022 Feb 3;139(5):651-665. doi: 10.1182/blood.2021012231. Blood. 2022. PMID: 34570885 Free PMC article.

10

miR-139-5p controls translation in myeloid leukemia through EIF4G2.

Emmrich S, Engeland F, El-Khatib M, Henke K, Obulkasim A, Schöning J, Katsman-Kuipers JE, Michel Zwaan C, Pich A, Stary J, Baruchel A, de Haas V, Reinhardt D, Fornerod M, van den Heuvel-Eibrink MM, Klusmann JH. Emmrich S, et al. Oncogene. 2016 Apr 7;35(14):1822-31. doi: 10.1038/onc.2015.247. Epub 2015 Jul 13. Oncogene. 2016. PMID: 26165837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page